Tag: LLC

CORAL SPRINGS, Fla., July 30, 2025 /PRNewswire/ -- Cruise Planners, the nation's largest home-based travel franchise network, continues to set the standard for franchisee...

WNC & Associates, MirKa Investments, LLC, and Mission Neighborhood Centers, Inc. begin construction on El Camino Real

WNC & Associates, MirKa Investments, LLC, and Mission Neighborhood Centers, Inc. begin construction on El Camino Real

SINGAPORE, July 30, 2025 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today announced that it has adopted a...

Advanced engineering partnership accelerates development of hydrothermal liquefaction systems for complex waste streams DENVER, July 30, 2025 /PRNewswire/ -- ReCircled LLC, a preprocessor for footwear, apparel and accessories, today contracted with Merrick...

FAIRVIEW PARK, Ohio, July 30, 2025 /PRNewswire/ -- The McGowan Companies ("McGowan") has acquired the assets associated with the Aegis Professional Risk ("Aegis Pro Risk")...

Founders Offer Do It Yourself Tick Control Tools and Resources WINDHAM, Maine, July 30, 2025 /PRNewswire/ -- Barb and Bob Maurais have launched Tick BYTES (Back Yard...

The Company expands and enhances its US flexible generation portfolio with its largest acquisition to date

The Company expands and enhances its US flexible generation portfolio with its largest acquisition to date

AUSTIN, Texas, July 30, 2025 /PRNewswire/ -- WhiteWater today announced the upsize of the Pelican Pipeline to a 42-inch from a 36-inch diameter pipeline....

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 30, 2025 /CNW/ - Palisades Goldcorp Ltd. (TSXV:...

Blue Ribbon LLC features a natural supplement formulated with key nutrients to help support men’s vitality, energy, and healthy testosterone levels.

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Larimar has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by Larimar. The offering is expected to close on or about July 31, 2025, subject to the satisfaction of customary closing conditions.